Thermo Fisher Scientific Life Sciences Solutions — Restructuring and other costs increased by 352.2% to $78.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 352.2%, from $17.25M to $78.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
High costs may indicate active operational improvement efforts, while consistently high levels could suggest ongoing integration challenges.
Expenses incurred by the Life Sciences Solutions segment related to organizational changes, such as facility consolidati...
Commonly reported by large, acquisitive firms undergoing periodic operational optimization.
tmo_segment_life_sciences_solutions_restructuring_and_other_costs| Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.00M | $5.00M | $26.25M | $26.25M | $26.25M | $26.25M | $17.25M | $17.25M | $17.25M | $17.25M | $78.00M |
| QoQ Change | — | +400.0% | +425.0% | +0.0% | +0.0% | +0.0% | -34.3% | +0.0% | +0.0% | +0.0% | +352.2% |
| YoY Change | — | — | >999% | +425.0% | — | — | -34.3% | -34.3% | -34.3% | -34.3% | +352.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.